Boston Sci Didn't Infringe Cordis Stent IP: Fed. Circ.

Law360, New York (September 28, 2011, 4:07 PM EDT) -- The Federal Circuit on Wednesday upheld a Delaware federal court ruling in a long-running dispute over heart stent technology, finding that Boston Scientific Corp. did not infringe a patent held by Johnson & Johnson subsidiary Cordis Corp. covering stents.

The appeals court upheld the decision by U.S. District Judge Sue L. Robinson, which granted of judgment as a matter of law that one of Cordis’ patents was not infringed by a Boston Scientific heart stent. However, the Federal Circuit also upheld the decision that the court...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.